SCHEMBL32688425

SCHEMBL32688425

CN1CCN(c2cccc(-c3cc(=O)[nH]c(SCc4nnn[nH]4)c3C#N)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 2/20 0.39
▸ CHEK1 O14757 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ RET P07949 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ PRKCB P05771 1/20 0.34
▸ PRKCA P17252 1/20 0.34
▸ PRKCH P24723 1/20 0.34
▸ PRKCE Q02156 1/20 0.34
▸ PRKCQ Q04759 1/20 0.34
▸ PRKCD Q05655 1/20 0.34
▸ BCL6 P41182 1/20 0.34
▸ DRD2 P14416 3/20 0.33
▸ DRD3 P35462 2/20 0.33
▸ RPS6KA3 P51812 1/20 0.33
▸ PRKD1 Q15139 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688199 0.93 HSD11B1 (0.36) KISS1RALDH1A1NPSR1DRD2DRD3
SCHEMBL32688472 0.92 GRK6 (0.36) KISS1RALDH1A1NPSR1
SCHEMBL32688310 0.91 GRK6 (0.37) KISS1RALDH1A1NPSR1BCL6
SCHEMBL32688163 0.91 KISS1R (0.39) KISS1RDRD2DRD3
SCHEMBL32687963 0.90 USP2 (0.37) KISS1RALDH1A1HSP90AA1HSP90AB1
SCHEMBL32688223 0.89 KISS1R (0.35) KISS1RALDH1A1
SCHEMBL32688418 0.88 HSD17B10 (0.40) KISS1RRETALDH1A1
SCHEMBL32688427 0.88 KISS1R (0.35) KISS1RALDH1A1
SCHEMBL32688118 0.86 CTSS (0.39) RETKCNH2VCP
SCHEMBL32688018 0.85 OTUD7B (0.40) ALDH1A1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KISS1R 3968/4885CHEK1 1557/4885ACHE 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback